RISTOCETIN is a new antimicrobial agent 1–3 produced by No cardia lurida, of large molecular size and active against gram-positive bacteria. It has been stated to be effective in the treatment of ...
Bleeding because of impaired platelet function is a major side effect of the Bruton’s tyrosine kinase (BTK) inhibitor ibrutinib. We quantitatively assessed ristocetin-induced platelet aggregation ...
To the Editor: Dr. Lowell A. Rantz and Dr. Ernest Jawetz reported in the November 13 issue of the Journal 3 cases of staphylococcal sepsis with bacteremia that had failed to respond to ristocetin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results